DE69528229T2 - N-substituierte beta-aryl und beta-heteroaryl-alpha-cyamoacrylamidderivate als tyrosine kinase inhibitoren - Google Patents
N-substituierte beta-aryl und beta-heteroaryl-alpha-cyamoacrylamidderivate als tyrosine kinase inhibitorenInfo
- Publication number
- DE69528229T2 DE69528229T2 DE69528229T DE69528229T DE69528229T2 DE 69528229 T2 DE69528229 T2 DE 69528229T2 DE 69528229 T DE69528229 T DE 69528229T DE 69528229 T DE69528229 T DE 69528229T DE 69528229 T2 DE69528229 T2 DE 69528229T2
- Authority
- DE
- Germany
- Prior art keywords
- beta
- alkyl
- pct
- hydrogen
- tyrosine kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9406137A GB9406137D0 (en) | 1994-03-28 | 1994-03-28 | N-substituted beta-aryl- and betaheteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation |
PCT/EP1995/000758 WO1995026341A1 (en) | 1994-03-28 | 1995-03-02 | Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69528229D1 DE69528229D1 (en) | 2002-10-24 |
DE69528229T2 true DE69528229T2 (de) | 2003-08-14 |
Family
ID=10752648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69528229T Expired - Fee Related DE69528229T2 (de) | 1994-03-28 | 1995-03-02 | N-substituierte beta-aryl und beta-heteroaryl-alpha-cyamoacrylamidderivate als tyrosine kinase inhibitoren |
Country Status (21)
Country | Link |
---|---|
US (1) | US5652250A (de) |
EP (1) | EP0700388B1 (de) |
JP (1) | JPH08511562A (de) |
KR (1) | KR960702442A (de) |
CN (1) | CN1125942A (de) |
AT (1) | ATE224371T1 (de) |
AU (1) | AU685599B2 (de) |
DE (1) | DE69528229T2 (de) |
ES (1) | ES2183866T3 (de) |
FI (1) | FI955661A (de) |
GB (1) | GB9406137D0 (de) |
HU (1) | HUT73811A (de) |
IL (1) | IL113044A0 (de) |
MX (1) | MX9504895A (de) |
MY (1) | MY130160A (de) |
NO (1) | NO954692L (de) |
NZ (1) | NZ281630A (de) |
PL (1) | PL311745A1 (de) |
TW (1) | TW347386B (de) |
WO (1) | WO1995026341A1 (de) |
ZA (1) | ZA952423B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9613021D0 (en) * | 1996-06-21 | 1996-08-28 | Pharmacia Spa | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
WO1997049653A2 (en) * | 1996-06-24 | 1997-12-31 | Irori | Solid phase tyrphostin library linked to matrices with memories |
JP2002504529A (ja) | 1998-02-27 | 2002-02-12 | ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 二置換ラベンダスティンa類似体およびこれらの類似体を含む薬学的組成物 |
HUP0000920A3 (en) * | 2000-02-28 | 2002-03-28 | Sanofi Synthelabo | Pde4 inhibitor isoquinolinylidene derivatives, process for their preparation and medicaments containing them |
CA2406160A1 (en) * | 2000-04-13 | 2001-10-25 | Hsc Research And Development Limited Partnership | Compounds for modulating cell proliferation |
EP1752446A3 (de) * | 2000-04-13 | 2007-03-21 | HSC Research and Development Limited Partnership | Verbindungen für die Modulation der Proliferation von Zellen |
CA2463133A1 (en) * | 2001-10-11 | 2003-04-17 | The Hospital For Sick Children | Styryl acrylonitrile compounds and their use to promote myelopoiesis |
EP1701941B1 (de) * | 2003-12-11 | 2012-05-30 | Board of Regents, The University of Texas System | Verbindungen zur behandlung von krankheiten mit zellproliferation |
JP2007530455A (ja) | 2004-03-26 | 2007-11-01 | エイチエスシー リサーチ アンド ディベロップメント リミテッド パートナーシップ | 細胞増殖を調節する化合物 |
US20100292229A1 (en) * | 2006-06-30 | 2010-11-18 | The Board Of Regents Of The University Of Texas System | Tryphostin-analogs for the treatment of cell proliferative diseases |
PL2307367T3 (pl) | 2008-07-08 | 2015-03-31 | Univ Texas | Nowe inhibitory proliferacji i aktywacji białek przekazujących sygnał i aktywujących transkrypcję (STAT) |
WO2011060440A2 (en) * | 2009-11-16 | 2011-05-19 | The Regents Of The University Of California | Kinase inhibitors |
CN103459371A (zh) * | 2011-04-02 | 2013-12-18 | 中国人民解放军军事医学科学院毒物药物研究所 | 芳基丙烯酰胺化合物及其用于制备免疫抑制剂的用途 |
WO2012158843A2 (en) * | 2011-05-17 | 2012-11-22 | The Regents Of The University Of California | Kinase inhibitors |
CA2860022A1 (fr) * | 2011-12-30 | 2013-07-04 | Universite D'auvergne Clermont I | Composes anti-douleur |
CN105705504A (zh) * | 2013-10-10 | 2016-06-22 | 密歇根大学董事会 | 去泛素化酶抑制剂及其使用方法 |
CN108276366B (zh) * | 2018-01-08 | 2021-09-03 | 四川大学 | 一种丙烯酰胺类衍生物及其制备方法与应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9000950D0 (en) * | 1990-01-16 | 1990-03-14 | Erba Carlo Spa | New arylvinylamide derivatives and process for their preparation |
GB9000939D0 (en) * | 1990-01-16 | 1990-03-14 | Erba Carlo Spa | Improvement in the total synthesis of erbstatin analogs |
GB9004483D0 (en) * | 1990-02-28 | 1990-04-25 | Erba Carlo Spa | New aryl-and heteroarylethenylene derivatives and process for their preparation |
CA2080582A1 (en) * | 1990-04-16 | 1991-10-17 | Alfred P. Spada | Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase |
US5196446A (en) * | 1990-04-16 | 1993-03-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Certain indole compounds which inhibit EGF receptor tyrosine kinase |
GB9115160D0 (en) * | 1991-07-12 | 1991-08-28 | Erba Carlo Spa | Methylen-oxindole derivatives and process for their preparation |
CA2080554A1 (en) * | 1991-10-15 | 1993-04-16 | Mitsubishi Chemical Corporation | Styrene derivatives |
GB9204945D0 (en) * | 1992-03-06 | 1992-04-22 | Erba Carlo Spa | 3-aryl-glycidic ester derivatives and process for their preparation |
GB9226855D0 (en) * | 1992-12-23 | 1993-02-17 | Erba Carlo Spa | Vinylene-azaindole derivatives and process for their preparation |
-
1994
- 1994-03-28 GB GB9406137A patent/GB9406137D0/en active Pending
-
1995
- 1995-03-02 EP EP95910542A patent/EP0700388B1/de not_active Expired - Lifetime
- 1995-03-02 JP JP7524920A patent/JPH08511562A/ja not_active Ceased
- 1995-03-02 AT AT95910542T patent/ATE224371T1/de not_active IP Right Cessation
- 1995-03-02 HU HU9503714A patent/HUT73811A/hu unknown
- 1995-03-02 WO PCT/EP1995/000758 patent/WO1995026341A1/en active IP Right Grant
- 1995-03-02 ES ES95910542T patent/ES2183866T3/es not_active Expired - Lifetime
- 1995-03-02 CN CN95190227A patent/CN1125942A/zh active Pending
- 1995-03-02 MX MX9504895A patent/MX9504895A/es unknown
- 1995-03-02 NZ NZ281630A patent/NZ281630A/en unknown
- 1995-03-02 DE DE69528229T patent/DE69528229T2/de not_active Expired - Fee Related
- 1995-03-02 KR KR1019950705290A patent/KR960702442A/ko not_active Application Discontinuation
- 1995-03-02 AU AU18498/95A patent/AU685599B2/en not_active Expired - Fee Related
- 1995-03-02 PL PL95311745A patent/PL311745A1/xx unknown
- 1995-03-02 US US08/537,947 patent/US5652250A/en not_active Expired - Fee Related
- 1995-03-15 MY MYPI95000645A patent/MY130160A/en unknown
- 1995-03-20 IL IL11304495A patent/IL113044A0/xx unknown
- 1995-03-23 TW TW084102825A patent/TW347386B/zh active
- 1995-03-24 ZA ZA952423A patent/ZA952423B/xx unknown
- 1995-11-20 NO NO954692A patent/NO954692L/no unknown
- 1995-11-24 FI FI955661A patent/FI955661A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1995026341A1 (en) | 1995-10-05 |
IL113044A0 (en) | 1995-06-29 |
HUT73811A (en) | 1996-09-30 |
US5652250A (en) | 1997-07-29 |
JPH08511562A (ja) | 1996-12-03 |
KR960702442A (ko) | 1996-04-27 |
ZA952423B (en) | 1995-12-19 |
FI955661A0 (fi) | 1995-11-24 |
EP0700388B1 (de) | 2002-09-18 |
GB9406137D0 (en) | 1994-05-18 |
NZ281630A (en) | 1998-02-26 |
TW347386B (en) | 1998-12-11 |
DE69528229D1 (en) | 2002-10-24 |
MY130160A (en) | 2007-06-29 |
AU685599B2 (en) | 1998-01-22 |
PL311745A1 (en) | 1996-03-18 |
CN1125942A (zh) | 1996-07-03 |
NO954692D0 (no) | 1995-11-20 |
HU9503714D0 (en) | 1996-02-28 |
NO954692L (no) | 1995-11-20 |
EP0700388A1 (de) | 1996-03-13 |
ES2183866T3 (es) | 2003-04-01 |
FI955661A (fi) | 1996-01-19 |
AU1849895A (en) | 1995-10-17 |
MX9504895A (es) | 1998-03-31 |
ATE224371T1 (de) | 2002-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69528229T2 (de) | N-substituierte beta-aryl und beta-heteroaryl-alpha-cyamoacrylamidderivate als tyrosine kinase inhibitoren | |
NO953146D0 (no) | Biologisk aktive 3-substituerte oksindolderivater som er nyttige som antiangiogeniske midler | |
CA2053253A1 (en) | New aryl-and heteroarylethenylene derivatives and process for their preparation | |
CA2286723A1 (en) | Tricyclic compounds | |
EA199800170A1 (ru) | Производные 2-(4-замещенного)бензиламино-2-метилпропанамида | |
MX9602979A (es) | Compuestos heterociclicos terapeuticos. | |
CA2135783A1 (en) | Substituted (arylalkoxybenzyl) amino-propanamide derivatives and process for their preparation | |
GB9306899D0 (en) | Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation | |
YU78100A (sh) | 4,5,6 i 7-indol i indolin derivati, njihova izrada i upotreba | |
CA2163115A1 (en) | N-substituted beta-aryl- and beta-heteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |